The economic returns of pediatric clinical trials of anti-hypertensive drugs

BACKGROUND: Congress has authorized the U.S. Food and Drug Administration (FDA) to provide industry sponsors with a 6-month extension of drug marketing rights under the Pediatric Exclusivity Provision if FDA-requested pediatric drug trials are conducted. The cost and economic return of pediatric exc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Baker-Smith, Carissa M., Benjamin, Daniel K., Grabowski, Henry G., Reid, Elizabeth D., Mangum, Barry, Goldsmith, John V., Murphy, M. Dianne, Edwards, Rex, Eisenstein, Eric L., Sun, Jessica, Califf, Robert M., Li, Jennifer S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3334305/
https://ncbi.nlm.nih.gov/pubmed/18926149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2008.05.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados